StockData
MannKind Corp logo

MannKind Corp (MNKD) stock

MNKDNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/30273% above fair value
$3.96−0.17 (-4.24%)

Close on Nov 16, 2026Market cap $1.27BP/E –Yield –

MannKind cash

Cash and short-term investments held at the end of each period.

MannKind's cash was $96.61M at Sep 30, 2026. For fiscal 2025 it was $171.35M, down 13.1% from the year before. Over ten years it grew 11.2% a year on average. The highest annual figure on record is $295.10M in fiscal 2023.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025$171.35M-13.1%
FY2024Dec 31, 2024$197.26M-33.2%
FY2023Dec 31, 2023$295.10M+72.7%
FY2022Dec 31, 2022$170.85M-16.3%
FY2021Dec 31, 2021$204.12M+204.6%
FY2020Dec 31, 2020$67.01M+34.3%
FY2019Dec 31, 2019$49.88M-29.9%
FY2018Dec 31, 2018$71.16M+61.9%
FY2017Dec 31, 2017$43.95M+91.9%
FY2016Dec 31, 2016$22.90M-61.2%
FY2015Dec 31, 2015$59.07M-51.1%
FY2014Dec 31, 2014$120.84M+70.7%
FY2013Dec 31, 2013$70.79M+14.5%
FY2012Dec 31, 2012$61.84M+2206.6%
FY2011Dec 31, 2011$2.68M-95.9%
FY2010Dec 31, 2010$66.06M+120.1%
FY2009Dec 31, 2009$30.02M+8.6%
FY2008Dec 31, 2008$27.65M–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$96.61M-62.8%
Q2 FY2026Jun 30, 2026$111.13M-37.9%
Q1 FY2026Mar 31, 2026$133.86M-26.3%
Q4 FY2025Dec 31, 2025$171.35M-13.1%
Q3 FY2025Sep 30, 2025$260.04M+3.4%
Q2 FY2025Jun 30, 2025$178.99M-27.8%
Q1 FY2025Mar 31, 2025$181.54M-39.6%
Q4 FY2024Dec 31, 2024$197.26M-33.2%
Q3 FY2024Sep 30, 2024$251.59M+78.4%
Q2 FY2024Jun 30, 2024$247.76M+71.6%
Q1 FY2024Mar 31, 2024$300.73M+81.0%
Q4 FY2023Dec 31, 2023$295.10M+72.7%
Q3 FY2023Sep 30, 2023$141.02M-14.6%
Q2 FY2023Jun 30, 2023$144.35M-6.4%
Q1 FY2023Mar 31, 2023$166.14M+2.3%
Q4 FY2022Dec 31, 2022$170.85M-16.3%
Q3 FY2022Sep 30, 2022$165.05M+18.7%
Q2 FY2022Jun 30, 2022$154.16M-5.1%
Q1 FY2022Mar 31, 2022$162.45M-41.3%
Q4 FY2021Dec 31, 2021$204.12M+204.6%
Q3 FY2021Sep 30, 2021$139.05M+165.4%
Q2 FY2021Jun 30, 2021$162.49M+157.0%
Q1 FY2021Mar 31, 2021$276.80M+612.1%
Q4 FY2020Dec 31, 2020$67.01M+34.3%
Q3 FY2020Sep 30, 2020$52.40M+4.7%
Q2 FY2020Jun 30, 2020$63.22M+92.3%
Q1 FY2020Mar 31, 2020$38.87M-34.4%
Q4 FY2019Dec 31, 2019$49.88M-29.9%
Q3 FY2019Sep 30, 2019$50.06M+379.2%
Q2 FY2019Jun 30, 2019$32.88M+25.6%
Q1 FY2019Mar 31, 2019$59.29M+122.0%
Q4 FY2018Dec 31, 2018$71.16M+61.9%
Q3 FY2018Sep 30, 2018$10.45M-48.0%
Q2 FY2018Jun 30, 2018$26.18M-39.7%
Q1 FY2018Mar 31, 2018$26.71M-44.3%
Q4 FY2017Dec 31, 2017$43.95M+91.9%
Q3 FY2017Sep 30, 2017$20.09M–
Q2 FY2017Jun 30, 2017$43.38M–
Q1 FY2017Mar 31, 2017$47.98M–
Q4 FY2016Dec 31, 2016$22.90M–

More MannKind figures

See a number that looks wrong?